During the most recent episode of Mad Money, Jim Cramer opened the show by emphasizing just how much American companies depend on China, during a time when the U.S. President is looking to strike a deal with the Chinese President:
“President Trump better be a much tougher negotiator than President Xi because right now we’re so hooked on China. It’s almost hard to believe. […] Every day I hear some company say that it’s doing its best to wean itself off China. But we depend on so much. We depend on them for manufacturing, on our goods, our raw materials that it’s just not easy. Sometimes it can’t even be done.“
READ ALSO: 10 Stock Predictions That Jim Cramer Got Right Again
Jim Cramer also gave his own view on the current administration’s trade strategy
“Some in the White House believe that allowing imports from Vietnam might give China a stealth way, a back door to get around the tariffs. Now, that’s why Vietnam’s tariffs from Liberation Day is 46%. That it’s crazy. China and Vietnam haven’t been buddy buddies since the early 70s. They still have periodic border disputes. It would be easy for our government to audit American companies from Vietnam to see where the goods originate, where this stuff comes from. Let’s be a little more rigorous, please. And Trump’s first term moving from China to Vietnam was the right move. Now it’s dead wrong. Retailers behind the scenes are furious, but who wants to be called out in this environment.”
Our Methodology
For this article, we compiled a list of 9 stocks that were discussed by Jim Cramer during the Mad Money episodes that aired between the 27th and 31st of May 2024. We then calculated their performance for the past 12 months, until June 4th, 2025, market close. We have also included the hedge fund sentiment for the stocks, which we sourced from Insider Monkey’s Q1 2025 database of over 900 hedge funds. The stocks are listed in the order that Cramer mentioned them.
Please note that this article mentions Jim Cramer’s previous opinions and may not account for any changes to his opinions regarding the stocks that are mentioned. It is primarily an examination of how his previously provided opinions have panned out.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
9. Novo Nordisk A/S (NYSE:NVO)
Number of Hedge Fund Holders: 60
In a prior call, a viewer asked about Novo Nordisk A/S (NYSE:NVO) as a long-term growth stock. Cramer gave it credit but made it clear he preferred Eli Lilly due to a promising Alzheimer’s-related drug in its pipeline. He said:
“NVO is a good growth stock… but I like Lilly better because Lilly may have, and it hasn’t happened yet, a little bit of a kick from another drug that it’s working on involving dementia… and I sure hope they solve it, but we’ve not seen anything about it yet.”
The pharma stock did not prove to be a growth stock at all, as it has declined by -49.32% since.
Novo Nordisk A/S (NYSE:NVO) is a Denmark-based pharmaceutical company that specializes in diabetes care, obesity treatments, and hormone replacement therapies.
Cramer continues to like Eli Lilly better. Here’s what he said about Novo on May 2:
“Next, did Novo Nordisk deliver a knockout punch to Eli Lilly when it signed a deal to be the preferred GLP-1 supplier to CVS on Lilly’s earnings day, no less? What a comeuppance. I think there’s plenty of gas in the Lily tank, especially once it tells it’s, you know, once it’s got this pill formulation that’s going to be available next year. I think it’s going to matter tremendously.”
Hedge Fund Resource Center